vs
Side-by-side financial comparison of GDEV Inc. (GDEV) and NovoCure Ltd (NVCR). Click either name above to swap in a different company.
NovoCure Ltd is the larger business by last-quarter revenue ($174.1M vs $119.9M, roughly 1.5× GDEV Inc.). GDEV Inc. runs the higher net margin — 13.9% vs -40.9%, a 54.7% gap on every dollar of revenue. On growth, GDEV Inc. posted the faster year-over-year revenue change (13.3% vs 12.3%).
GDEV Inc. is a gaming and entertainment holding company. It is a publicly traded company listed on the Nasdaq stock exchange, headquartered in Limassol, Cyprus. The holding was evolved in June 2023 from a video game company Nexters, founded in 2014, one of the top five independent mobile game companies in Europe. Subsidiaries of GDEV include Nexters Studio, which operates offices in Cyprus, Armenia, and Kazakhstan, as well as Cubic Games, Royal Ark, Game Gears and Light Hour Games. The compan...
NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.
GDEV vs NVCR — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $119.9M | $174.1M |
| Net Profit | $16.6M | $-71.1M |
| Gross Margin | — | 77.6% |
| Operating Margin | 15.5% | — |
| Net Margin | 13.9% | -40.9% |
| Revenue YoY | 13.3% | 12.3% |
| Net Profit YoY | 13.0% | -107.3% |
| EPS (diluted) | $0.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $174.1M | ||
| Q4 25 | — | $174.3M | ||
| Q3 25 | — | $167.2M | ||
| Q2 25 | $119.9M | $158.8M | ||
| Q1 25 | — | $155.0M | ||
| Q4 24 | — | $161.3M | ||
| Q3 24 | — | $155.1M | ||
| Q2 24 | $105.8M | $150.4M |
| Q1 26 | — | $-71.1M | ||
| Q4 25 | — | $-24.5M | ||
| Q3 25 | — | $-37.3M | ||
| Q2 25 | $16.6M | $-40.1M | ||
| Q1 25 | — | $-34.3M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | — | $-30.6M | ||
| Q2 24 | $14.7M | $-33.4M |
| Q1 26 | — | 77.6% | ||
| Q4 25 | — | 75.8% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | — | 73.9% | ||
| Q1 25 | — | 75.1% | ||
| Q4 24 | — | 79.2% | ||
| Q3 24 | — | 77.2% | ||
| Q2 24 | — | 77.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | -23.2% | ||
| Q3 25 | — | -21.5% | ||
| Q2 25 | 15.5% | -24.9% | ||
| Q1 25 | — | -24.4% | ||
| Q4 24 | — | -39.3% | ||
| Q3 24 | — | -20.7% | ||
| Q2 24 | 14.4% | -22.3% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | — | -14.1% | ||
| Q3 25 | — | -22.3% | ||
| Q2 25 | 13.9% | -25.3% | ||
| Q1 25 | — | -22.1% | ||
| Q4 24 | — | -40.9% | ||
| Q3 24 | — | -19.7% | ||
| Q2 24 | 13.9% | -22.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.33 | ||
| Q2 25 | $0.90 | $-0.36 | ||
| Q1 25 | — | $-0.31 | ||
| Q4 24 | — | $-0.61 | ||
| Q3 24 | — | $-0.28 | ||
| Q2 24 | $0.81 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $432.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-129.4M | $330.7M |
| Total Assets | $210.2M | $787.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $432.0M | ||
| Q4 25 | — | $93.5M | ||
| Q3 25 | — | $342.1M | ||
| Q2 25 | $41.6M | $149.6M | ||
| Q1 25 | — | $127.3M | ||
| Q4 24 | — | $163.8M | ||
| Q3 24 | — | $185.4M | ||
| Q2 24 | $50.8M | $164.8M |
| Q1 26 | — | $330.7M | ||
| Q4 25 | — | $340.5M | ||
| Q3 25 | — | $341.3M | ||
| Q2 25 | $-129.4M | $349.4M | ||
| Q1 25 | — | $362.0M | ||
| Q4 24 | — | $360.2M | ||
| Q3 24 | — | $360.8M | ||
| Q2 24 | $-118.7M | $361.8M |
| Q1 26 | — | $787.9M | ||
| Q4 25 | — | $804.3M | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $210.2M | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $282.8M | $1.2B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
